000908 *ST景峰醫藥
按盤價 
3.590 +0.020 (+0.560%)
3.590 +0.020 (+0.560%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 38.755 | -373.215 | -54.114 | -43.523 | -98.320 |
| 總資產報酬率 ROA (%) | -2.290 | -17.089 | -7.585 | -6.887 | -27.773 |
| 投入資產回報率 ROIC (%) | -3.723 | -27.391 | -11.048 | -9.446 | -36.179 | 邊際利潤分析 |
| 銷售毛利率 (%) | 62.943 | 71.758 | 76.288 | 62.087 | 63.785 |
| 營業利潤率 (%) | -9.683 | -26.322 | -8.127 | -15.401 | -115.668 |
| 息稅前利潤/營業總收入 (%) | -1.180 | -20.233 | -4.084 | -7.205 | -106.815 |
| 淨利潤/營業總收入 (%) | -10.270 | -31.436 | -11.331 | -23.506 | -119.279 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 125.214 | 78.419 | 58.938 | 249.946 | 62.127 |
| 價值變動淨收益/利潤總額(%) | 2.053 | -16.647 | -16.140 | -177.348 | -21.375 |
| 營業外收支淨額/利潤總額(%) | 3.885 | 0.435 | 20.220 | 13.530 | 2.713 | 償債能力分析 |
| 流動比率 (X) | 0.170 | 0.205 | 0.527 | 0.498 | 0.550 |
| 速動比率 (X) | 0.123 | 0.143 | 0.416 | 0.384 | 0.425 |
| 資產負債率 (%) | 117.122 | 114.493 | 86.166 | 82.557 | 77.107 |
| 帶息債務/全部投入資本 (%) | 96.099 | 92.295 | 70.987 | 70.087 | 68.523 |
| 股東權益/帶息債務 (%) | -12.298 | -8.148 | 25.432 | 31.484 | 31.313 |
| 股東權益/負債合計 (%) | -6.147 | -4.077 | 13.121 | 19.678 | 20.160 |
| 利息保障倍數 (X) | -0.133 | -3.261 | -0.669 | -0.679 | -8.844 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 53.923 | 67.168 | 79.197 | 143.424 | 233.146 |
| 存貨周轉天數 (天) | 140.311 | 179.444 | 249.019 | 226.966 | 316.292 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 27/09/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
